Avenue Therapeutics to Host Virtual Annual Meeting of Stockholders
NEW YORK, May 29, 2020 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development […]
NEW YORK, May 29, 2020 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development […]
HAMILTON, Bermuda, May 29, 2020 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, […]
TORONTO, May 29, 2020 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan”) (TSX: REI.UN) today announced that it is […]
Undifferentiated Pleomorphic Sarcoma is the Major Sarcoma Subtype to be Enrolled inTRACON’s Pivotal ENVASARC Trial of Envafolimab as a Single Agent […]
The addition of ublituximab to ibrutinib significantly improved PFS, ORR, CR rate, and increased rates of uMRD compared with ibrutinib […]
SAN DIEGO, May 29, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation […]
Phase 3 data presented in oral presentation during the ASCO20 Virtual Scientific Program, with simultaneous publication in the New England […]
Mondelēz International contributed to JDE Peet’s successful listing on Euronext AmsterdamCompany will retain two board seats at the global coffee […]
REDIRECT is a Registration-directed Phase II Open-label Multicenter Study to Assess the Efficacy and Safety of AFM13 in Patients with […]
BELTSVILLE, Md., May 29, 2020 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]